Literature DB >> 1738999

MR imaging of extraabdominal desmoids: differentiation from other neoplasms.

T E Hartman1, T H Berquist, J F Fetsch.   

Abstract

A retrospective review of MR images of 36 patients with histologically proved extraabdominal desmoids was done to define the MR characteristics of these tumors and to determine if MR could be used to differentiate desmoids from other benign and malignant soft-tissue neoplasms. The desmoids evaluated included eight primary and 30 recurrent lesions. Our study was conducted in parallel with another study in which the MR appearance of 95 benign and malignant soft-tissue masses was evaluated, and the MR images of these masses were compared with our findings. The four desmoids from that study are included in our data. The signal intensity of the tumor on T1- and T2-weighted images was graded relative to the intensities of muscle and fat. Homogeneity, margin, neurovascular and bone involvement, and fibrosis (low-signal regions within the tumor on both T1- and T2-weighted images) were evaluated. On MR imaging, the desmoids showed inhomogeneous signal (97%), poor margination (89%), neurovascular involvement (58%), and bone involvement (37%). Fibrosis was present in 88% of primary desmoids and 90% of recurrent ones, and intermediate signal (greater than that of muscle and less than that of fat) was present in 75% and 50% of these, respectively. Our results show that the MR features of desmoids have characteristics that are commonly found in malignant tumors (inhomogeneous signal, poor margination, and neurovascular involvement). MR features of desmoids that distinguish them from malignant neoplasms are the presence of fibrosis and intermediate signal in the regions of the tumor.

Entities:  

Mesh:

Year:  1992        PMID: 1738999     DOI: 10.2214/ajr.158.3.1738999

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Imaging of superficial and deep fibromatosis.

Authors:  G Guglielmi; A Cifaratti; G Scalzo; N Magarelli
Journal:  Radiol Med       Date:  2009-09-30       Impact factor: 3.469

2.  Multimodal radiological imaging of collagenous fibroma arising from the subacromial region in a patient with osteosarcoma: A case report.

Authors:  Hiroaki Murata; Kan Imai; Kazuya Nakagawa; Yasunori Nishigaki
Journal:  Mol Clin Oncol       Date:  2019-01-09

3.  Role of technetium-99m pertechnetate scintigraphy in the management of extra-abdominal fibromatosis.

Authors:  S Terui; T Terauchi; H Abe; Y Muramatsu; H Fukuma; Y Beppu; R Yokoyama
Journal:  Skeletal Radiol       Date:  1995-07       Impact factor: 2.199

4.  Case report 818: Pericapsular desmoid tumor of the knee.

Authors:  L Yao; S Toranji; S A Doberneck; J J Eckardt
Journal:  Skeletal Radiol       Date:  1994-04       Impact factor: 2.199

5.  Natural evolution of desmoplastic fibroblastoma on magnetic resonance imaging: a case report.

Authors:  Yusaku Kamata; Ukei Anazawa; Hideo Morioka; Takeshi Morii; Keiko Miura; Makio Mukai; Hiroo Yabe; Yoshiaki Toyama
Journal:  J Med Case Rep       Date:  2011-04-07

Review 6.  Desmoid type fibromatosis in the facet joint of lumbar spine: case report and review of literature.

Authors:  So Jung Kim; Doo Hoe Ha; Sang Min Lee; Haeyoun Kang
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

7.  MR imaging for preoperative diagnosis and assessment of local tumor extent on localized giant cell tumor of tendon sheath.

Authors:  Yasuyuki Kitagawa; Hiromoto Ito; Yasuo Amano; Takuya Sawaizumi; Toshitsugu Takeuchi
Journal:  Skeletal Radiol       Date:  2003-09-20       Impact factor: 2.199

8.  Desmoplastic fibroma of bone: a report of 18 cases.

Authors:  W K Taconis; H E Schütte; R O van der Heul
Journal:  Skeletal Radiol       Date:  1994-05       Impact factor: 2.199

Review 9.  An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).

Authors:  B Kasper; C Baumgarten; J Garcia; S Bonvalot; R Haas; F Haller; P Hohenberger; N Penel; C Messiou; W T van der Graaf; A Gronchi
Journal:  Ann Oncol       Date:  2017-10-01       Impact factor: 32.976

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.